The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1.
Rare MBD gene glitches appear in some autistic people, but we still don’t know how that should steer ABA plans.
01Research in Context
What this study did
Scientists scanned DNA from 287 people with autism and matched controls.
They hunted for rare changes in MBD genes—genes that help package DNA.
The team found new spelling changes in MBD6 and SETDB1 plus a MECP2 duplication.
What they found
Rare MBD gene variants showed up in some autistic participants.
No behavior data were collected; this was a pure gene-hunt paper.
How this fits with other research
Peters et al. (2013) extends the MECP2 finding by showing boys with the duplication act like ASD kids—social delays are milder but repetitive behaviors are just as strong.
Ohashi et al. (2021) pulls the rug back: in a big clinical sample only 1 in 10 non-syndromic ASD cases get a clear genetic answer, so most MBD variants still have unknown meaning.
Melnyk et al. (2012) adds a metabolic twist—autistic kids show low DNA methylation and oxidative stress, hinting these MBD variants might actually disrupt methylation in the body.
Why it matters
You will not change therapy based on this paper alone.
Still, if genetic reports list MBD6, SETDB1, or MECP2 changes, expect an autism-like profile and watch for subtle social strengths.
Pair the report with the child’s real-world skills and keep using your usual ABA tools while the science catches up.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →File the genetic report in the client’s medical chart and keep running your baseline VB-MAPP—no program changes yet.
02At a glance
03Original abstract
The methyl-CpG-binding domain (MBD) gene family was first linked to autism over a decade ago when Rett syndrome, which falls under the umbrella of autism spectrum disorders (ASDs), was revealed to be predominantly caused by MECP2 mutations. Since that time, MECP2 alterations have been recognized in idiopathic ASD patients by us and others. Individuals with deletions across the MBD5 gene also present with ASDs, impaired speech, intellectual difficulties, repetitive behaviors, and epilepsy. These findings suggest that further investigations of the MBD gene family may reveal additional associations related to autism. We now describe the first study evaluating individuals with ASD for rare variants in four autosomal MBD family members, MBD5, MBD6, SETDB1, and SETDB2, and expand our initial screening in the MECP2 gene. Each gene was sequenced over all coding exons and evaluated for copy number variations in 287 patients with ASD and an equal number of ethnically matched control individuals. We identified 186 alterations through sequencing, approximately half of which were novel (96 variants, 51.6%). We identified 17 ASD specific, nonsynonymous variants, four of which were concordant in multiplex families: MBD5 Tyr1269Cys, MBD6 Arg883Trp, MECP2 Thr240Ser, and SETDB1 Pro1067del. Furthermore, a complex duplication spanning of the MECP2 gene was identified in two brothers who presented with developmental delay and intellectual disability. From our studies, we provide the first examples of autistic patients carrying potentially detrimental alterations in MBD6 and SETDB1, thereby demonstrating that the MBD gene family potentially plays a significant role in rare and private genetic causes of autism.
Autism research : official journal of the International Society for Autism Research, 2012 · doi:10.1002/aur.1251